(Q39816193)

English

Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Markus Sperandio

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Gary B. Calandra

5

object named as

Gary Calandra

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Falk Dillmann

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Marlon R Veldwijk

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Stephanie Laufs

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Frederik Wenz

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Jens Zeller

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Stephan Fruehauf

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

1 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1676-1686

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL--Inhibition of P-glycoprotein function by 17-AAG.

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Overriding imatinib resistance with a novel ABL kinase inhibitor

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells.

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Efficient long-term maintenance of chronic myeloid leukemic cobblestone area forming cells on a murine stromal cell line.

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Combination therapy with imatinib mesylate (STI571): synopsis of in vitro studies

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism.

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

CXCR4 is a prognostic marker in acute myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1.

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Autoperfused mouse flow chamber reveals synergistic neutrophil accumulation through P-selectin and E-selectin

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Synergistic mobilization of hemopoietic progenitor cells using concurrent beta1 and beta2 integrin blockade or beta2-deficient mice.

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Imatinib restores expression of CD62L in BCR-ABL-positive cells

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Immobilized stromal cell-derived factor-1alpha triggers rapid VLA-4 affinity increases to stabilize lymphocyte tethers on VCAM-1 and subsequently initiate firm adhesion

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Adhesion to fibronectin stimulates proliferation of wild-type and bcr/abl-transfected murine hematopoietic cells

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Mechanisms underlying abnormal trafficking and expansion of malignant progenitors in CML: BCR/ABL-induced defects in integrin function in CML.

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

In vivo effects of imatinib mesylate on human haematopoietic progenitor cells.

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

p210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190903150847

21 January 2018

Identifiers

10.1080/10428190903150847

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39816193&oldid=2090838375"